AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 AUG 1 - (NewsRx.com & NewsRx.net) -- Findings reported at the 10th World Congress on the Menopause in Berlin, Germany, have confirmed previous results indicating the health benefits for women who take the red clover isoflavone supplement Promensil, manufactured by Novogen Limited (NVGN).
The study, reported by Arturo Jeri of the Institute of Gynecology and Reproduction, Lima, Peru, was a double-blind, placebo-controlled trial involving 100 menopausal women selected on the basis of having moderately elevated blood cholesterol.
The study finds that women taking Promensil for three months maintained cholesterol levels better than women taking a placebo. There were no adverse effects reported. This result builds on previous findings of a statically significant improvement in the acute symptoms of menopause such as hot flashes among women using Promensil.
"This is an exciting study that gives further support to the link between red clover isoflavone supplements, such as Promensil and Rimostil and the maintenance of cardiovascular health in postmenopausal women," said Jeri.
"As women age and estrogen levels decline, their so-called 'good' HDL ...